MRCM
GILD icon

M&R Capital Management’s Gilead Sciences GILD Stock Holding History

M&R Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$6K – 414
2021
Q3 		$6K Hold
100
– – ﹤0.01% 360
2021
Q2 		$6K Hold
100
– – ﹤0.01% 361
2021
Q1 		$6K Sell
100
-200
-67% -$12.9K ﹤0.01% 355
2020
Q4 		$17K Sell
300
-250
-45% -$15.1K ﹤0.01% 317
2020
Q3 		$34K Hold
550
– – 0.01% 268
2020
Q2 		$42K Hold
550
– – 0.01% 250
2020
Q1 		$41K Hold
550
– – 0.01% 255
2019
Q4 		$35K Buy
550
+250
+83% +$16.3K 0.01% 288
2019
Q3 		$19K Buy
300
+100
+50% +$6.54K ﹤0.01% 354
2019
Q2 		$13K Hold
200
– – ﹤0.01% 396
2019
Q1 		$13K Hold
200
– – ﹤0.01% 397
2018
Q4 		$12K Hold
200
– – ﹤0.01% 396
2018
Q3 		$15K Hold
200
– – ﹤0.01% 404
2018
Q2 		$14K Hold
200
– – ﹤0.01% 406
2018
Q1 		$15K Hold
200
– – ﹤0.01% 409
2017
Q4 		$14K Sell
200
-1,000
-83% -$75.9K ﹤0.01% 418
2017
Q3 		$97K Buy
1,200
+1,000
+500% +$76.5K 0.02% 236
2017
Q2 		$14K Hold
200
– – ﹤0.01% 415
2017
Q1 		$13K Sell
200
-7,434
-97% -$523K ﹤0.01% 426
2016
Q4 		$546K Sell
7,634
-3,800
-33% -$282K 0.15% 113
2016
Q3 		$904K Buy
11,434
+4
+0% +$325 0.26% 86
2016
Q2 		$953K Buy
11,430
+525
+5% +$46.6K 0.28% 79
2016
Q1 		$1M Buy
10,905
+625
+6% +$56.4K 0.3% 72
2015
Q4 		$1.04M Buy
10,280
+300
+3% +$31.2K 0.3% 72
2015
Q3 		$980K Buy
9,980
+6,550
+191% +$727K 0.27% 75
2015
Q2 		$402K Sell
3,430
-200
-6% -$21.9K 0.1% 142
2015
Q1 		$356K Buy
3,630
+50
+1% +$5.08K 0.08% 156
2014
Q4 		$337K Buy
3,580
+1,180
+49% +$122K 0.08% 158
2014
Q3 		$255K Sell
2,400
-200
-8% -$19.6K 0.06% 183
2014
Q2 		$216K Buy
+2,600
New +$202K 0.05% 194

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

M&R Capital Management's GILD Position: Q4 2021 in Review

M&R Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 100 shares — an estimated $6K sold.

M&R Capital Management first reported a position in GILD in Q2 2014 and held it in 30 quarters. The position peaked at $1.04M in Q4 2015. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • M&R Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • M&R Capital Management sold 100 Gilead Sciences shares in Q4 2021, an estimated $6K.
  • M&R Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 30 quarters.
  • M&R Capital Management's Gilead Sciences position peaked at $1.04M in Q4 2015.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on M&R Capital Management's 13F filing for Q4 2021, filed 7 Jan 2022.